ImpediMed Limited (ASX:IPD)
Australia · Delayed Price · Currency is AUD 0.0060
0.00 (0.00%)
Jul 17, 2026, 4:10 PM AEST
ImpediMed Market Cap
ImpediMed has a market cap or net worth of 14.03 million as of July 17, 2026. Its market cap has decreased by -83.12% in one year.
Market Cap
14.03M
Enterprise Value
16.74M
Revenue
14.23M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.01
ChartMarket Cap Chart
Since October 24, 2007, ImpediMed's market cap has decreased from 67.49M to 14.03M, a decrease of -79.21%. That is a compound annual growth rate of -8.04%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2026 | 14.03M | -79.76% |
| Dec 31, 2025 | 69.30M | -34.16% |
| Dec 31, 2024 | 105.26M | -64.12% |
| Dec 29, 2023 | 293.38M | 108.23% |
| Dec 30, 2022 | 140.90M | -54.66% |
| Dec 31, 2021 | 310.77M | 130.93% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Compumedics | 44.95M |
| HeraMED | 43.98M |
| CleanSpace Holdings | 31.56M |
| Nova Eye Medical | 31.33M |
| Control Bionics | 30.49M |
| Micro-X | 25.43M |
| Memphasys | 24.70M |
| Atomo Diagnostics | 14.44M |